TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18044014

Group type: EXPERIMENTAL
Intervention: Electrogram-guided ablation (EGA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Infusion of isoproterenol (20 mug/min) during repeat ablation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Repeat ablation targeting CFAEs and mapping all pulmonary veins (PVs)
Number of subjects: 30
Study: 15019120

Group type: EXPERIMENTAL
Intervention: Glutamine granules 0.5 g/kg orally for 14 days
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (same dosage as glutamine) for 14 days
Number of subjects: 48
Study: 11805533

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg)
Number of subjects: 1145
Study: 9935254

Group type: EXPERIMENTAL
Intervention: 200 mg trovafloxacin once daily for 10 days
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 7755476

Group type: EXPERIMENTAL
Intervention: cilazapril 2.5-5 mg per day
Number of subjects: 17

Group type: COMPARATOR
Intervention: atenolol 25-100 mg per day
Number of subjects: 17
Study: 2971977

Group type: EXPERIMENTAL
Intervention: Metered dose aerosol of 200 micrograms fenoterol plus 80 micrograms ipratropium bromide ('Duovent')
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dry powder preparation for inhalation ('Inhalets') of 200 micrograms fenoterol plus 80 micrograms ipratropium bromide ('Duovent')
Number of subjects: 20
Study: 31449165

Group type: EXPERIMENTAL
Intervention: Augmented PROMs (Patient-Reported Outcome Measures) provided to primary care physicians
Number of subjects: 304

Group type: COMPARATOR
Intervention: Control clinics (standard care without augmented PROMs)
Number of subjects: 304
Study: 28347865

Group type: EXPERIMENTAL
Intervention: Mechanical curettage with adjunct antimicrobial photodynamic therapy (aPDT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Mechanical curettage alone
Number of subjects: 48
Study: 24841947

Group type: EXPERIMENTAL
Intervention: The Incredible Years Parent‐Toddler Programme (IYPTP)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 89
Study: 23458681

Group type: EXPERIMENTAL
Intervention: Mesh reinforcement of stapled left pancreatectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No mesh reinforcement of stapled left pancreatectomy
Number of subjects: 0
Study: 20848527

Group type: EXPERIMENTAL
Intervention: Boswelan (3×2 capsules/day; 400 mg each)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Boswelan
Number of subjects: 108
Study: 19918682

Group type: EXPERIMENTAL
Intervention: Healer cream applied 3 times daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nitroglycerine 0.25% cream applied 3 times daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lidocaine 2% cream applied 3 times daily
Number of subjects: 60
Study: 17096821

Group type: EXPERIMENTAL
Intervention: School-based obesity prevention programs
Number of subjects: 0
Study: 12719046

Group type: EXPERIMENTAL
Intervention: Propofol (1 mg/kg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Etomidate (0.2 mg/kg)
Number of subjects: 34
Study: 10911589

Group type: EXPERIMENTAL
Intervention: Home health nursing intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no home health nursing services)
Number of subjects: 0
Study: 9580234

Group type: EXPERIMENTAL
Intervention: Diet + 750 mg UDA + fiber placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diet + 15 g Pp + UDA placebo
Number of subjects: 0
Study: 8503064

Group type: EXPERIMENTAL
Intervention: AIDS educational programs
Number of subjects: 301
Study: 3759281

Group type: EXPERIMENTAL
Intervention: L-carnitine, 2 g twice daily for 15 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31278329

Group type: EXPERIMENTAL
Intervention: Sanghuang-Danshen (SD) phytochemicals
Number of subjects: 17
Study: 29902995

Group type: EXPERIMENTAL
Intervention: Specialist Depression Service (SDS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 21
Study: 26798960

Group type: EXPERIMENTAL
Intervention: Text messaging‐based smoking cessation intervention
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 187
Study: 24288121

Group type: EXPERIMENTAL
Intervention: Topotecan (0.75 mg/m²) on days 1, 2, and 3, etoposide (70 mg/m²) and cisplatin (20 mg/m²) on days 8, 9, and 10 (Arm A)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Irinotecan (50 mg/m²) and cisplatin (20 mg/m²) on days 1 and 8 followed by etoposide (85 mg/m² PO bid) on days 3 and 10 (Arm B)
Number of subjects: 140
Study: 22044970

Group type: EXPERIMENTAL
Intervention: Titanium spiral tacks (STs)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Tissue adhesive (TA)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 19671086

Group type: EXPERIMENTAL
Intervention: Morphine (0.08 mg/kg)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Pentazocine (0.5 mg/kg)
Number of subjects: 212
Study: 19095597

Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg once daily for 4 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Spironolactone in microalbuminuria group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Spironolactone in macroalbuminuria group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 24
Study: 15751766

Group type: EXPERIMENTAL
Intervention: Individualized multicomponent intervention (nurse-led, motivational interviewing, 3 months, 4 encounters)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Usual medical follow-up
Number of subjects: 151
Study: 12486433

Group type: EXPERIMENTAL
Intervention: Inoue balloon technique (IBMC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Metallic commissurotomy (PMMC)
Number of subjects: 100
Study: 9797112

Group type: COMPARATOR
Intervention: Control medium
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Liposomal lecithin (1 mg/mL for 2 hours)
Number of subjects: 25
Study: 8635827

Group type: EXPERIMENTAL
Intervention: Deferiprone (DFP) given to 20 patients (10 beta thalassemia, 10 hemoglobin E-beta thalassemia)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (21 patients)
Number of subjects: 41
Study: 2569381

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 4 x 1 g i.m. every 2 days
Number of subjects: 28

Group type: COMPARATOR
Intervention: Penicillin G 1 million IU i.m. daily for 15 days
Number of subjects: 28
Study: 773078

Group type: EXPERIMENTAL
Intervention: Piracetam
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 27
Study: 31237981

Group type: EXPERIMENTAL
Intervention: Chinese ear acupuncture
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: French ear acupuncture
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 111
Study: 28854534

Group type: EXPERIMENTAL
Intervention: Dexamethasone 4 mg i.v. after induction of anaesthesia
Number of subjects: 32

Group type: COMPARATOR
Intervention: Saline (Control group)
Number of subjects: 32
Study: 26267418

Group type: EXPERIMENTAL
Intervention: Antidepressants (ADs) plus mood stabilizers continued for up to 3 years after achieving euthymia for 2 months
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Antidepressants (ADs) continued
Number of subjects: 70

Group type: COMPARATOR
Intervention: Antidepressants (ADs) discontinued
Number of subjects: 70
Study: 23792189

Group type: EXPERIMENTAL
Intervention: Patient Education plus Manual Therapy (PE + MT)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Patient Education (PE)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Minimal Control Intervention (MCI)
Number of subjects: 118
Study: 22089463

Group type: EXPERIMENTAL
Intervention: IV golimumab 2‐4 mg/kg (± MTX) every 12 weeks
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: golimumab 50 mg SC (± MTX) every 4 weeks
Number of subjects: 643

Group type: COMPARATOR
Intervention: IV placebo + MTX
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: golimumab (IV) + MTX
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: SC golimumab (LTE)
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: IV golimumab (2‐4 mg/kg)
Number of subjects: 643
Study: 19097679

Group type: EXPERIMENTAL
Intervention: Light cola drink (group light)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Regular cola drink (group regular)
Number of subjects: 8
Study: 16598368

Group type: EXPERIMENTAL
Intervention: Fracture group
Number of subjects: 125

Group type: COMPARATOR
Intervention: No fracture group
Number of subjects: 125
Study: 14630265

Group type: EXPERIMENTAL
Intervention: (125)I (144 Gy)
Number of subjects: 115

Group type: COMPARATOR
Intervention: (103)Pd (125 Gy)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: D(90) <100%
Number of subjects: 115

Group type: COMPARATOR
Intervention: D(90) >=100%
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: V(100) <90%
Number of subjects: 115

Group type: COMPARATOR
Intervention: V(100) >=90%
Number of subjects: 115
Study: 16989935

Group type: EXPERIMENTAL
Intervention: Clinical assessment by auscultation
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Clinical assessment by palpation
Number of subjects: 26

Group type: COMPARATOR
Intervention: Electrocardiography (ECG)
Number of subjects: 26
Study: 10392323

Group type: EXPERIMENTAL
Intervention: Avitriptan (12.7 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Avitriptan (25.3 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Avitriptan (38.0 mg)
Number of subjects: 24
Study: 9133311

Group type: EXPERIMENTAL
Intervention: Diltiazem (0.3 mg/Kg bolus, followed by 0.0028 mg/Kg/min infusion if needed)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Verapamil (75 micrograms/Kg bolus, with a second dose if needed)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Sokolow protocol (i.v. digital plus oral quinidine 400 to 1,200 mg)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Diltiazem and Verapamil
Number of subjects: 160
Study: 1899392

Group type: EXPERIMENTAL
Intervention: hMG/IUI
Number of subjects: 322

Group type: COMPARATOR
Intervention: hMG
Number of subjects: 322

Group type: COMPARATOR
Intervention: IUI
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: hMG/IUI (for male factor)
Number of subjects: 322

Group type: COMPARATOR
Intervention: hMG (for male factor)
Number of subjects: 322

Group type: COMPARATOR
Intervention: IUI (for male factor)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: hMG/IUI (for cervical factor)
Number of subjects: 322

Group type: COMPARATOR
Intervention: hMG (for cervical factor)
Number of subjects: 322

Group type: COMPARATOR
Intervention: IUI (for cervical factor)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: hMG/IUI (for endometriosis)
Number of subjects: 322

Group type: COMPARATOR
Intervention: hMG (for endometriosis)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: hMG/IUI (for unexplained infertility)
Number of subjects: 322

Group type: COMPARATOR
Intervention: hMG (for unexplained infertility)
Number of subjects: 322

Group type: COMPARATOR
Intervention: IUI (for unexplained infertility)
Number of subjects: 322
Study: 6344736

Group type: EXPERIMENTAL
Intervention: Doxycycline 400 mg
Number of subjects: 147

Group type: COMPARATOR
Intervention: Metronidazole 1500 mg
Number of subjects: 147
Study: 27430157

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC; 4 × 5-min at 220 mmHg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: SHAM-RIPC (20 mmHg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: RIPC
Number of subjects: 14

Group type: COMPARATOR
Intervention: RIPC and SHAM-RIPC
Number of subjects: 14
Study: 26723098

Group type: EXPERIMENTAL
Intervention: Double cord technique with 5% aluminum chloride cords
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Diode laser (810 nm)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (adjacent tooth)
Number of subjects: 6
Study: 25158654

Group type: EXPERIMENTAL
Intervention: Fall-prevention DVD program
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard fall-prevention education (Control)
Number of subjects: 132
Study: 21791146

Group type: EXPERIMENTAL
Intervention: Global DNA methylation measured in leucocytes
Number of subjects: 215
Study: 19018865

Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation (ASCT) with melphalan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Induction therapy including new drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consolidation with a second transplant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maintenance with thalidomide after ASCT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of an alkylating drug with a novel agent
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Corticosteroids plus bortezomib, thalidomide or lenalidomide
Number of subjects: 0
Study: 17243997

Group type: EXPERIMENTAL
Intervention: OFD + NBM + GTR (test)
Number of subjects: 19

Group type: COMPARATOR
Intervention: OFD alone (control)
Number of subjects: 19
Study: 15747820

Group type: EXPERIMENTAL
Intervention: Lingual appliances (Group LI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Labial appliances (Group LA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 12215058

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fluoxetine and sertraline
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Paroxetine and citalopram
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SSRIs
Number of subjects: 12

Group type: COMPARATOR
Intervention: Serotonergic antidepressants
Number of subjects: 12
Study: 9626835

Group type: EXPERIMENTAL
Intervention: Pravastatin treatment
Number of subjects: 255
Study: 8087361

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 2811958

Group type: EXPERIMENTAL
Intervention: Boiled coffee (4 to 6 cups a day)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Filtered coffee (4 to 6 cups a day)
Number of subjects: 107

Group type: COMPARATOR
Intervention: No coffee
Number of subjects: 107

Group type: COMPARATOR
Intervention: Filtered coffee
Number of subjects: 107
Study: 30939272

Group type: EXPERIMENTAL
Intervention: Communication Skills Intensive training
Number of subjects: 65
Study: 28109543

Group type: EXPERIMENTAL
Intervention: Everolimus (1.5 mg or 3 mg) with reduced cyclosporine
Number of subjects: 95

Group type: COMPARATOR
Intervention: Mycophenolate sodium and standard exposure cyclosporine
Number of subjects: 95
Study: 25464424

Group type: EXPERIMENTAL
Intervention: Exercise training (12 week standardized aerobic dynamic exercise training program)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control (continued lifestyle and received care as usual)
Number of subjects: 93
Study: 25798518

Group type: EXPERIMENTAL
Intervention: High-quality foster care with specialized training and support
Number of subjects: 2

Group type: COMPARATOR
Intervention: Government-sponsored foster care
Number of subjects: 2
Study: 22795453

Group type: EXPERIMENTAL
Intervention: Extended-release mixed amphetamine salts (MAS-ER) and topiramate
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 20689928

Group type: EXPERIMENTAL
Intervention: Patients confident in extubation success (confidents; n = 115)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Patients not confident in extubation success (non-confidents; n = 38)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Control group (patients not subjected to interview; n = 58)
Number of subjects: 211
Study: 17279307

Group type: EXPERIMENTAL
Intervention: 5‐mm LigaSure
Number of subjects: 30

Group type: COMPARATOR
Intervention: 10‐mm LigaSure
Number of subjects: 30
Study: 16218799

Group type: EXPERIMENTAL
Intervention: Fenofibrate 200 mg
Number of subjects: 174

Group type: COMPARATOR
Intervention: Pravastatin 40 mg
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Combination therapy (Fenofibrate + Pravastatin)
Number of subjects: 174
Study: 12359197

Group type: EXPERIMENTAL
Intervention: Daily aspiration of seroma
Number of subjects: 36

Group type: COMPARATOR
Intervention: Aspiration as required by patient symptoms
Number of subjects: 36
Study: 10416042

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 100 mg twice daily
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 7559695

Group type: EXPERIMENTAL
Intervention: Enoxaparin (administered at 12 hours preoperatively and 12 and 36 hours postoperatively)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group (no enoxaparin)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 156
Study: 2288819

Group type: EXPERIMENTAL
Intervention: Isometric handgrip (IHG)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bicycle ergometric exercise (BEE)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tyramine infusion (TI)
Number of subjects: 40
Study: 7234190

Group type: EXPERIMENTAL
Intervention: Calcitonin
Number of subjects: 0

Group type: COMPARATOR
Intervention: No Calcitonin (Control)
Number of subjects: 0
Study: 31487365

Group type: EXPERIMENTAL
Intervention: Center-based (CB) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Home-based (HB) intervention
Number of subjects: 0
Study: 28085904

Group type: EXPERIMENTAL
Intervention: Toy with smaller-sized meal bundle (420 calories)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Regular-sized meal bundle (580 calories)
Number of subjects: 109
Study: 25845222

Group type: EXPERIMENTAL
Intervention: Acupoint injection of kakkonein (2 mL) into bilateral Fengchi (GB 20), once every other day for 8 weeks
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Acupuncture (bilateral GB 20 acupoints punctured with filiform needles), once every other day for 8 weeks
Number of subjects: 135

Group type: COMPARATOR
Intervention: Oral administration of compound levodopa (125 mg, twice a day) for 8 weeks
Number of subjects: 135
Study: 23975654

Group type: EXPERIMENTAL
Intervention: Vortioxetine co-administered with bupropion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vortioxetine co-administered with fluconazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vortioxetine co-administered with ketoconazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vortioxetine co-administered with rifampicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vortioxetine co-administered with ethinyl estradiol/levonorgestrel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vortioxetine co-administered with 5'-hydroxyomeprazole
Number of subjects: 0
Study: 20869142

Group type: EXPERIMENTAL
Intervention: Rotating-bearing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fixed-bearing arthroplasty
Number of subjects: 0
Study: 19215678

Group type: EXPERIMENTAL
Intervention: Soybean oil (SBO)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Rice bran oil (RBO)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Palm oil (PO)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: RBO/PO mixture (3:1)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control diet (8-week period)
Number of subjects: 16
Study: 17918294

Group type: EXPERIMENTAL
Intervention: Cisplatin 20 mg/m(2), days 1‐5, every 21 days (arm A, n=171)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Cisplatin 40 mg/m(2)/weekly (arm B, n=164)
Number of subjects: 335

Group type: COMPARATOR
Intervention: Both arms
Number of subjects: 335
Study: 15503750

Group type: EXPERIMENTAL
Intervention: PRRR training (five 8-hour training modules)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 232
Study: 11522955

Group type: EXPERIMENTAL
Intervention: Patients with parietal lobe pathology
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study: 9294777

Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of bovine TSH, 10 units daily for 3 days
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Daily oral administration of L‐triiodothyronine 75 micrograms for 7 days
Number of subjects: 17

Group type: COMPARATOR
Intervention: Normal responses (> 50%) in nine subjects
Number of subjects: 17
Study: 7870742

Group type: EXPERIMENTAL
Intervention: New generation antidepressants (maprotiline, mianserin, viloxazine, trazodone, nomifensine, fluvoxamine, fluoxetine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study: 3346364

Group type: EXPERIMENTAL
Intervention: Sulpiride (100 mg, three times daily for 4 days, then 50 mg, three times daily for 90 days)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Sulpiride
Number of subjects: 66
Study: 29724350

Group type: EXPERIMENTAL
Intervention: Drug-Eluting Stents (DES)
Number of subjects: 610

Group type: COMPARATOR
Intervention: Bare-Metal Stents
Number of subjects: 610
Study: 27073063

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging-guided focused ultrasound surgery
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Uterine artery embolization
Number of subjects: 49

Group type: COMPARATOR
Intervention: Randomized participants
Number of subjects: 49

Group type: COMPARATOR
Intervention: Nonrandomized participants
Number of subjects: 49
Study: 25023791

Group type: EXPERIMENTAL
Intervention: Intramyocardial bone marrow cell (BMC) injection (97 ± 13 × 10(6) BMCs)
Number of subjects: 120
Study: 22680341

Group type: EXPERIMENTAL
Intervention: Namisol® (5 mg THC) - Sublingual administration
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Namisol® (6.5 mg and 8.0 mg THC) - Oral administration
Number of subjects: 12

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 12
Study: 19763743

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DPO) targeting hemoglobin (Hb) of 12-13 g/dl
Number of subjects: 0

Group type: COMPARATOR
Intervention: Epoetin alfa (EPO) targeting conventional Hb
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correction of anemia to 11 g/dl or more
Number of subjects: 0
Study: 18417519

Group type: EXPERIMENTAL
Intervention: TENS (transcutaneous electrical nerve stimulation)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 45